Given the contrasting correlation of MLH1 expression with colon versus breast cancer survival probability (Figure 1, H–J) and the observation that most BRCA2 mutation carriers develop ERα-positive (ER+) breast cancer, we investigated MLH1 expression in breast tissues. This evidence concerns the gene BRCA2 and breast cancer.